EP0666761A4 - Stimulation of an antitumor t-cell response using anti-idiotypic antibodies. - Google Patents
Stimulation of an antitumor t-cell response using anti-idiotypic antibodies.Info
- Publication number
- EP0666761A4 EP0666761A4 EP93920425A EP93920425A EP0666761A4 EP 0666761 A4 EP0666761 A4 EP 0666761A4 EP 93920425 A EP93920425 A EP 93920425A EP 93920425 A EP93920425 A EP 93920425A EP 0666761 A4 EP0666761 A4 EP 0666761A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- antitumor
- stimulation
- cell response
- idiotypic antibodies
- idiotypic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000005867 T cell response Effects 0.000 title 1
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 230000000638 stimulation Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39566—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against immunoglobulins, e.g. anti-idiotypic antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
- C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
- C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US938079 | 1978-08-30 | ||
US93807992A | 1992-08-31 | 1992-08-31 | |
PCT/US1993/008163 WO1994005329A1 (en) | 1992-08-31 | 1993-08-31 | Stimulation of an antitumor t-cell response using anti-idiotypic antibodies |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0666761A1 EP0666761A1 (en) | 1995-08-16 |
EP0666761A4 true EP0666761A4 (en) | 1996-07-17 |
Family
ID=25470841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP93920425A Withdrawn EP0666761A4 (en) | 1992-08-31 | 1993-08-31 | Stimulation of an antitumor t-cell response using anti-idiotypic antibodies. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0666761A4 (en) |
JP (1) | JPH08502954A (en) |
AU (1) | AU5097393A (en) |
CA (1) | CA2139743A1 (en) |
WO (1) | WO1994005329A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5798100A (en) * | 1994-07-06 | 1998-08-25 | Immunomedics, Inc. | Multi-stage cascade boosting vaccine |
US7354587B1 (en) | 1994-07-06 | 2008-04-08 | Immunomedics, Inc. | Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
ATE235514T1 (en) | 1994-12-28 | 2003-04-15 | Univ Kentucky | MONOCLONAL ANTI-IDIOTYPIC ANTIBODY 3H1 FROM MOUSE |
US6949244B1 (en) | 1995-12-20 | 2005-09-27 | The Board Of Trustees Of The University Of Kentucky | Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof |
EP1032583A4 (en) * | 1998-03-06 | 2005-02-02 | Imclone Systems Inc | Active immunization against angiogenesis-associated antigens |
US6376654B1 (en) * | 1999-08-13 | 2002-04-23 | Molecular Discoveries, Llc | Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof |
US7226750B1 (en) | 2000-08-08 | 2007-06-05 | Molecular Discoveries, Inc. | Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
US8562988B2 (en) | 2005-10-19 | 2013-10-22 | Ibc Pharmaceuticals, Inc. | Strategies for improved cancer vaccines |
US8551480B2 (en) | 2004-02-13 | 2013-10-08 | Immunomedics, Inc. | Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity |
US8652484B2 (en) | 2004-02-13 | 2014-02-18 | Immunomedics, Inc. | Delivery system for cytotoxic drugs by bispecific antibody pretargeting |
US8435539B2 (en) | 2004-02-13 | 2013-05-07 | Immunomedics, Inc. | Delivery system for cytotoxic drugs by bispecific antibody pretargeting |
US9481878B2 (en) | 2004-02-13 | 2016-11-01 | Immunomedics, Inc. | Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity |
WO2010022225A1 (en) | 2008-08-20 | 2010-02-25 | Ibc Pharmaceuticals, Inc. | Dock-and-lock (dnl) vaccines for cancer therapy |
-
1993
- 1993-08-31 EP EP93920425A patent/EP0666761A4/en not_active Withdrawn
- 1993-08-31 JP JP6507378A patent/JPH08502954A/en active Pending
- 1993-08-31 CA CA002139743A patent/CA2139743A1/en not_active Abandoned
- 1993-08-31 AU AU50973/93A patent/AU5097393A/en not_active Abandoned
- 1993-08-31 WO PCT/US1993/008163 patent/WO1994005329A1/en not_active Application Discontinuation
Non-Patent Citations (5)
Title |
---|
BHATTACHARYA-CHATTERJEE M. ET AL., INTERNATIONAL REVIEWS OF IMMUNOLOGY, vol. 7, no. 4, 1991, pages 289 - 302, XP000570399 * |
HERLYN D.ET AL., INTERNATIONAL REVIEWS OF IMMUNOLOGY, vol. 7, no. 4, 1991, pages 245 - 257, XP000569562 * |
RAYCHAUDHURI S. ET AL., CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, vol. 9, no. 2, 1989, pages 109 - 124, XP000569759 * |
RAYCHAUDHURI S. ET AL., JOURNAL OF IMMUNOLOGY, vol. 139, no. 6, 15 September 1987 (1987-09-15), BALTIMORE US, pages 2096 - 2102, XP002003096 * |
See also references of WO9405329A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1994005329A1 (en) | 1994-03-17 |
AU5097393A (en) | 1994-03-29 |
JPH08502954A (en) | 1996-04-02 |
EP0666761A1 (en) | 1995-08-16 |
CA2139743A1 (en) | 1994-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2265754B (en) | Silicon transducer | |
AU1573688A (en) | Membrane-gel diffusion device | |
AU116079S (en) | Ring | |
HK1010797A1 (en) | Hydrophone arrangement | |
GB9223172D0 (en) | Capsule construction | |
GB2272345B (en) | Hydrophones | |
EP0666761A4 (en) | Stimulation of an antitumor t-cell response using anti-idiotypic antibodies. | |
EP0586828A3 (en) | Hydrophone. | |
IL103349A0 (en) | Ring | |
AU4377793A (en) | Alternative receptor therapy | |
GB9023730D0 (en) | Explosive lines | |
ZA962552B (en) | Explosive | |
GB9205850D0 (en) | Explosive arrangements | |
EP0599601A3 (en) | Analysis of vibrating panels. | |
IL102866A0 (en) | Metallocenes as anti-tumor drugs | |
EP0554085A3 (en) | Hydrophone | |
ZA929091B (en) | Ear ring for stimulating acupuncture points. | |
AU4529793A (en) | Endogenous ligands for cdr4 of t-cell receptor beta -chains and genes encoding the same | |
GB9501804D0 (en) | Well-logging device | |
AU8123687A (en) | Antiidiotypic t-cell hybridoma | |
HUT73886A (en) | Reference elektrode free from the diffusion potential | |
ZA937642B (en) | Explosives | |
BG96050A (en) | Explosive | |
ZW16993A1 (en) | Explosives. | |
GB9212650D0 (en) | Transducer elements |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19950210 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19960531 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19980303 |